Summary

Report Scope
This report provides an overview of the pharmaceutical business and the function of contract development and manufacturing organizations (CDMOs). The analysis includes a review of the global CDMO market by service type, drug molecule type and end use. It also examines the regulatory policies, standards and inspection trends of the global CDMO markets. In addition, the competitive environment, significant rivals, significant leaders and top 10 manufacturers in the CDMO sector are also reviewed.
The report presents a detailed description of the service types (API manufacturing services, drug product/finished drug manufacturing service, pharmaceutical development services and analytical testing and regulatory support services) and current and historical market revenues. The CDMO markets are also segmented based on type of molecule (small-molecule drugs, biologics and advanced therapies) and end user (clinical and commercial). The market revenue for each geographic segment (North America, Europe, Asia-Pacific and the Rest of the World) has also been provided in the report.
In order to provide an in-depth understanding of the market, profiles of market participants, competitive landscape, key competitors and respective market share are also included in this report. For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.
Report Includes
- 76 data tables and 32 additional tables
- An overview of the global contract development and manufacturing organization (CDMO) market
- Analysis of the global market trends, with data from 2021-2022, estimates for 2023, forecast for 2024, and projections of compound annual growth rates (CAGRs) through 2029
- Estimates of the market size and revenue forecast for the CDMO market, and a corresponding market share analysis based on type of service, drug molecule type, end user, and region
- Evaluation of the market potential and opportunities for pharmaceutical CDMOs, regulatory policies, standards and inspection trends
- Identifying the pharma companies that are considered leaders in their field, as well as the technological means these companies are using to exploit their markets
- A look at the competitive landscape of the global CDMO market, featuring companies contracting with a contract manufacturing outsourcer for both clinical and commercial stage manufacturing
- A discussion of the ESG challenges and practices in the CDMO industry
- An analysis of the market shares of key companies in the industry as well as their proprietary technologies and strategic alliances
- Profiles of the leading players, including Thermo Fisher Scientific Inc., Merck KGaA, Lonza, Catalent Inc., and WuXi AppTec

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Value Chain Analysis
Small-Molecule Drugs
Biologics
Advanced Therapy Medical Products
PESTEL Analysis of the Pharmaceutical Industry
Political Factors
Economic Factors
Social Factors
Technological Factors
Environmental Factors
Legal Factors
Chapter 3 Market Dynamics
Global Market Dynamics
Market Drivers
Increase in Pharmaceutical Outsourcing Practices
Pressure on R&D Spending
Rising Demand for Advanced Therapeutics
Upsurge in the Number of Clinical Trials
Market Restraints
Strict Regulations and Compliance Requirements
Shortage of Skilled Technical Personnel
Strong Competition in Cost, Technology and Service Ranges
Market Opportunities
Inorganic Growth
Chapter 4 Emerging Trends
Overview
Increased Focus on Biologics and Cell and Gene Therapy
Integration of Digital Technologies
Collaborative Risk Management
Chapter 5 Regulatory Landscape
Overview
Good Manufacturing Practice (GMP)
Quality Assurance and Quality Control
Regulatory Submissions
Environmental & Safety Regulations
International Standards
Data Integrity & Security
Labeling & Packaging
Audits and Inspections
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Market Breakdown by Type of Service
API Manufacturing Services
Drug Product/Finished Drug Manufacturing Services
Pharmaceutical Development Services
Analytical Testing and Regulatory Support Services
Market Breakdown by Type of Molecule
Small-molecule Drugs
Biologics
Advanced Therapies
Market Breakdown by End User
Clinical
Commercial
Geographic Breakdown
Market Breakdown by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Overview
New Entrants in Market
Global Market Shares of Leading Companies
Chapter 8 Sustainability in CDMO Market: ESG Perspective
Overview
Green Chemistry and Pharmaceutical Manufacturing
Considering Sustainability through the Development Cycle and Across the Supply Chain
Sustainability in the CDMO industry
Environmental Considerations
Social Considerations
Governance Factors
ESG Risk Ratings
Conclusion
Chapter 9 Appendix
Methodology
Sources
Abbreviations
Company Profiles
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
CATALENT INC.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES
LONZA
MERCK KGAA
RECIPHARM AB
SAMSUNG BIOLOGICS
SIEGFRIED HOLDING AG
THERMO FISHER SCIENTIFIC INC.
WUXI APPTEC